{"title":"Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management","authors":"","doi":"10.6004/jadpro.2019.10.2.14","DOIUrl":null,"url":null,"abstract":"Look: • Does the patient appear uncomfortable? • Does the patient appear unwell? • Is there an obvious rash? • Is the patient scratching during the visit? • Is skin integrity intact? • Are there skin changes? » Xerosis (dry skin) » Changes in skin pigment or color • Is there oral involvement of the rash? • Does the rash involve the genitalvaginal region? The scalp? Listen: • Does the patient have pruritus with or without rash? • Is there a rash with or without pruritus? • Are symptoms interfering with ADLs? • With sleep? • Have symptoms worsened? Recognize: • Is there a history of dermatitis, preexisting skin issues (psoriasis, eczema, wounds, prior radiation to region, etc.)? • Laboratory abnormalities consistent with other etiologies (e.g., eosinophils on complete blood count, liver function abnormalities) Appendix A. Care Step Pathway: Skin Toxicities","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"10 1","pages":"63 - 95"},"PeriodicalIF":0.0000,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the advanced practitioner in oncology","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.6004/jadpro.2019.10.2.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Look: • Does the patient appear uncomfortable? • Does the patient appear unwell? • Is there an obvious rash? • Is the patient scratching during the visit? • Is skin integrity intact? • Are there skin changes? » Xerosis (dry skin) » Changes in skin pigment or color • Is there oral involvement of the rash? • Does the rash involve the genitalvaginal region? The scalp? Listen: • Does the patient have pruritus with or without rash? • Is there a rash with or without pruritus? • Are symptoms interfering with ADLs? • With sleep? • Have symptoms worsened? Recognize: • Is there a history of dermatitis, preexisting skin issues (psoriasis, eczema, wounds, prior radiation to region, etc.)? • Laboratory abnormalities consistent with other etiologies (e.g., eosinophils on complete blood count, liver function abnormalities) Appendix A. Care Step Pathway: Skin Toxicities